Australia markets open in 9 hours 26 minutes

NeuBase Therapeutics, Inc. (NBSE)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.4340+0.0130 (+3.09%)
As of 09:53AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 1.58M
Enterprise value -5.66M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)0.17
Enterprise value/revenue N/A
Enterprise value/EBITDA 0.19

Trading information

Stock price history

Beta (5Y monthly) 0.96
52-week change 3-84.05%
S&P500 52-week change 322.64%
52-week high 34.8000
52-week low 30.3900
50-day moving average 30.6843
200-day moving average 30.8016

Share statistics

Avg vol (3-month) 3239.86k
Avg vol (10-day) 359.52k
Shares outstanding 53.75M
Implied shares outstanding 63.75M
Float 83.3M
% held by insiders 113.38%
% held by institutions 112.69%
Shares short (15 Apr 2024) 424.46k
Short ratio (15 Apr 2024) 40.11
Short % of float (15 Apr 2024) 40.70%
Short % of shares outstanding (15 Apr 2024) 40.65%
Shares short (prior month 15 Mar 2024) 480.45k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 304 Feb 2019
Ex-dividend date 4N/A
Last split factor 21:20
Last split date 315 June 2023

Financial highlights

Fiscal year

Fiscal year ends 30 Sept 2022
Most-recent quarter (mrq)30 Sept 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-43.03%
Return on equity (ttm)-93.46%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -23.41M
Net income avi to common (ttm)-24.59M
Diluted EPS (ttm)-18.6000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)12.57M
Total cash per share (mrq)3.37
Total debt (mrq)5.34M
Total debt/equity (mrq)58.39%
Current ratio (mrq)7.40
Book value per share (mrq)2.45

Cash flow statement

Operating cash flow (ttm)-24.69M
Levered free cash flow (ttm)-15.18M